Stockscreener 앱 받기
0.00
100.00%
-23.50
시간 외 거래:
23.49
23.49
+
Assertio Holdings Inc 주식(ASRT)의 최신 뉴스
Assertio Holdings (NASDAQ: ASRT) common stock struck from Nasdaq list - Stock Titan
Assertio Deadline Alert - TMX Newsfile
ASRT CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Assertio Holdings, Inc. (ASRT) Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - TMX Newsfile
ASRT Stock Drops After-Hours On Discounted Buyout Deal — Retail Calls It A ‘Robbery’ - Stocktwits
Zydus Lifesciences Completes Acquisition of Assertio Holdings - Machine Maker
[15-12G] Assertio Holdings, Inc. SEC Filing - Stock Titan
ASRT Q1 2026 Earnings: Steep EPS Miss Amid Silent Revenue DisclosuresEarnings Revision Downgrade - dars.gov.et
Zydus’s acquisition of Assertio to bolster its specialty pharma presence in US market - Indian Pharma Post
Zydus Lifesciences Completes Acquisition of Assertio; Nasdaq Delisting Confirmed - Digital Health News
Assertio Holdings Inc (ASRT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Assertio Holdings Inc (ASRT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Assertio Holdings Inc (ASRT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Zydus Acquires Assertio for Oncology Growth - Chemical Industry Digest
[EFFECT] Assertio Holdings, Inc. SEC Filing - Stock Titan
Assertio Holdings Inc (ASRT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Zydus Completes USD 166.4 Million Acquisition of US-Based Assertio Holdings - Medical Dialogues
Key facts: Assertio appoints two directors; Nasdaq halt, delisting - TradingView
Assertio Holdings Completes Merger with Zydus Lifesciences; Shareholders Receive $23.50 Per Share in Cash 1 - Minichart
Zydus Lifesciences Completes Acquisition of US-Based Assertio Holdings - marketscreener.com
Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 million - inkl
Assertio completes $23.50 per share merger with Zydus - Investing.com UK
Assertio (ASRT) director fully cashes out shares and options in Zydus $23.50-per-share merger - Stock Titan
Zydus buys Assertio (ASRT); EVP Schlessinger equity cashed out at $23.50 - Stock Titan
Assertio Holdings (ASRT) director exits as Zydus cash merger pays $23.50 - Stock Titan
Assertio (ASRT) director’s shares and options cashed out in $23.50 Zydus buyout - Stock Titan
Assertio (ASRT) COO exits stock, options and RSUs in $23.50-per-share cash merger - Stock Titan
Assertio (ASRT) CEO exits all shares and awards in $23.50-per-share cash merger - Stock Titan
Assertio (ASRT) director cashes out shares and options in Zydus merger - Stock Titan
Assertio (ASRT) director fully cashed out as $23.50-per-share merger closes - Stock Titan
CFO Ajay Patel exits Assertio (ASRT) stake in $23.50-per-share merger - Stock Titan
Zydus completes Assertio acquisition, notes repurchase rights triggered - scanx.trade
Assertio Amends 2027 Convertible Notes After Merger; Holders Get Cash-Only Conversion, Put Right - TradingView
Assertio Holdings (ASRT) completes merger; deregisters $250M shelf capacity - Stock Titan
Assertio Holdings (ASRT) deregisters S-4s after $23.50 cash tender and merger - Stock Titan
Acquirer completes Assertio deal; ASRT removed registered shares after $23.50 tender - Stock Titan
Assertio completes $23.50 per share merger with Zydus By Investing.com - Investing.com Australia
Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026 - marketscreener.com
Zydus buys Assertio (NASDAQ: ASRT) in $23.50‑per‑share all‑cash deal - Stock Titan
Zydus deal gives Assertio holders $23.50 cash per share - Stock Titan
Zydus Lifesciences completes acquisition of Assertio - ET Manufacturing
Zydus Lifesciences shares in focus on completing acquisition of Assertio Holdings; key details - Upstox
Assertio (ASRT) moves 17.0% higher: Will this strength last? - MSN
Assertio (ASRT) tendered 66.32% of shares; merger to close June 16, 2026 - Stock Titan
Zydus Lifesciences (NASDAQ: ASRT) completes $23.50-per-share tender offer - Stock Titan
Assertio Holdings, Inc.(NasdaqCM: ASRT) dropped from S&P TMI Index - marketscreener.com
Assertio Holdings, Inc.(NasdaqGM: ASRT) dropped from NASDAQ Composite Index - marketscreener.com
Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders? - Sahm
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Via Transportation, Inc. - GlobeNewswire Inc.
Ademi LLP probes Assertio Holdings' $23.50/share deal over possible shareholder rights violations - Pluang
Shareholder Alert: Ademi LLP investigates whether Assertio - GlobeNewswire
Assertio Deadline Reminder - TMX Newsfile
Nantahala Capital Management, LLC Sells Out of Assertio Holdings Inc - GuruFocus
0.15%
1.95%
자본화:
|
볼륨(24시간):